Cargando…

Hyperhemolysis Syndrome in a Patient with Sickle Cell Disease: A Case Report

INTRODUCTION: Hyperhemolysis syndrome (HHS) is a rare complication of repeat blood transfusions in sickle cell disease (SCD). This can occur acutely or have a delayed presentation and often goes unrecognized in the emergency department (ED) due to its rapid progression and similarity to acute chest...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalter, Joshua A., Gupta, Ranju, Greenberg, Marna Rayl, Miller, Andrew J., Allen, Jamie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: University of California Irvine, Department of Emergency Medicine publishing Western Journal of Emergency Medicine 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872616/
https://www.ncbi.nlm.nih.gov/pubmed/33560964
http://dx.doi.org/10.5811/cpcem.2020.12.50349
_version_ 1783649224451162112
author Kalter, Joshua A.
Gupta, Ranju
Greenberg, Marna Rayl
Miller, Andrew J.
Allen, Jamie
author_facet Kalter, Joshua A.
Gupta, Ranju
Greenberg, Marna Rayl
Miller, Andrew J.
Allen, Jamie
author_sort Kalter, Joshua A.
collection PubMed
description INTRODUCTION: Hyperhemolysis syndrome (HHS) is a rare complication of repeat blood transfusions in sickle cell disease (SCD). This can occur acutely or have a delayed presentation and often goes unrecognized in the emergency department (ED) due to its rapid progression and similarity to acute chest syndrome and other common complications of SCD. CASE REPORT: We present a case of a 20-year-old male with SCD who presented to the ED with pain and tenderness in his lower extremities one day after discharge for a crisis. Unbeknownst to the ED team, during his admission he had received a blood transfusion. On presentation he was noted to have hyperkalemia, hyperbilirubinemia, anemia, and uncontrolled pain, and was admitted for sickle cell pain crisis. Over the next 36 hours, his hemoglobin dropped precipitously from 8.9 grams per deciliter (g/dL) to 4.2 g/dL (reference range: 11.5–14.5 g/dL), reticulocyte count from 11.7 % to 3.8% (0.4–2.2%), and platelets from 318,000 per cubic centimeter (K/cm(3)) to 65 K/cm(3) (140–350 K/cm(3)). He also developed a fever, hypoxia, transaminitis, a deteriorating mental status, and severe lactic acidosis. Hematology was consulted and he was treated with methylprednisolone, intravenous immunoglobulin, two units of antigen-matched red blood cells, fresh frozen plasma, and cryoprecipitate. He was transferred to an outside hospital for exchange transfusion and remained hospitalized for 26 days with acute liver failure, bone marrow necrosis, and a fever of unknown origin. CONCLUSION: Because of the untoward outcomes associated with delay in HHS diagnosis and the need for early initiation of steroids, it is important for emergency providers to screen patients with hemoglobinopathies for recent transfusion at ED presentation. Asking the simple question about when a patient’s last transfusion occurred can lead an emergency physician to include HHS in the differential and work-up of patients with sickle cell disease complications.
format Online
Article
Text
id pubmed-7872616
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher University of California Irvine, Department of Emergency Medicine publishing Western Journal of Emergency Medicine
record_format MEDLINE/PubMed
spelling pubmed-78726162021-02-12 Hyperhemolysis Syndrome in a Patient with Sickle Cell Disease: A Case Report Kalter, Joshua A. Gupta, Ranju Greenberg, Marna Rayl Miller, Andrew J. Allen, Jamie Clin Pract Cases Emerg Med Case Report INTRODUCTION: Hyperhemolysis syndrome (HHS) is a rare complication of repeat blood transfusions in sickle cell disease (SCD). This can occur acutely or have a delayed presentation and often goes unrecognized in the emergency department (ED) due to its rapid progression and similarity to acute chest syndrome and other common complications of SCD. CASE REPORT: We present a case of a 20-year-old male with SCD who presented to the ED with pain and tenderness in his lower extremities one day after discharge for a crisis. Unbeknownst to the ED team, during his admission he had received a blood transfusion. On presentation he was noted to have hyperkalemia, hyperbilirubinemia, anemia, and uncontrolled pain, and was admitted for sickle cell pain crisis. Over the next 36 hours, his hemoglobin dropped precipitously from 8.9 grams per deciliter (g/dL) to 4.2 g/dL (reference range: 11.5–14.5 g/dL), reticulocyte count from 11.7 % to 3.8% (0.4–2.2%), and platelets from 318,000 per cubic centimeter (K/cm(3)) to 65 K/cm(3) (140–350 K/cm(3)). He also developed a fever, hypoxia, transaminitis, a deteriorating mental status, and severe lactic acidosis. Hematology was consulted and he was treated with methylprednisolone, intravenous immunoglobulin, two units of antigen-matched red blood cells, fresh frozen plasma, and cryoprecipitate. He was transferred to an outside hospital for exchange transfusion and remained hospitalized for 26 days with acute liver failure, bone marrow necrosis, and a fever of unknown origin. CONCLUSION: Because of the untoward outcomes associated with delay in HHS diagnosis and the need for early initiation of steroids, it is important for emergency providers to screen patients with hemoglobinopathies for recent transfusion at ED presentation. Asking the simple question about when a patient’s last transfusion occurred can lead an emergency physician to include HHS in the differential and work-up of patients with sickle cell disease complications. University of California Irvine, Department of Emergency Medicine publishing Western Journal of Emergency Medicine 2021-01-26 /pmc/articles/PMC7872616/ /pubmed/33560964 http://dx.doi.org/10.5811/cpcem.2020.12.50349 Text en Copyright: © 2021 Kalter et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) License. See: http://creativecommons.org/licenses/by/4.0/
spellingShingle Case Report
Kalter, Joshua A.
Gupta, Ranju
Greenberg, Marna Rayl
Miller, Andrew J.
Allen, Jamie
Hyperhemolysis Syndrome in a Patient with Sickle Cell Disease: A Case Report
title Hyperhemolysis Syndrome in a Patient with Sickle Cell Disease: A Case Report
title_full Hyperhemolysis Syndrome in a Patient with Sickle Cell Disease: A Case Report
title_fullStr Hyperhemolysis Syndrome in a Patient with Sickle Cell Disease: A Case Report
title_full_unstemmed Hyperhemolysis Syndrome in a Patient with Sickle Cell Disease: A Case Report
title_short Hyperhemolysis Syndrome in a Patient with Sickle Cell Disease: A Case Report
title_sort hyperhemolysis syndrome in a patient with sickle cell disease: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7872616/
https://www.ncbi.nlm.nih.gov/pubmed/33560964
http://dx.doi.org/10.5811/cpcem.2020.12.50349
work_keys_str_mv AT kalterjoshuaa hyperhemolysissyndromeinapatientwithsicklecelldiseaseacasereport
AT guptaranju hyperhemolysissyndromeinapatientwithsicklecelldiseaseacasereport
AT greenbergmarnarayl hyperhemolysissyndromeinapatientwithsicklecelldiseaseacasereport
AT millerandrewj hyperhemolysissyndromeinapatientwithsicklecelldiseaseacasereport
AT allenjamie hyperhemolysissyndromeinapatientwithsicklecelldiseaseacasereport